Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An update from Chimeric Therapeutics Ltd. ( (AU:CHM) ) is now available.
Chimeric Therapeutics Limited has announced a proposed issue of securities, including options and ordinary fully paid shares, to raise capital. This strategic move is aimed at enhancing the company’s financial position and supporting its ongoing research and development efforts in the biotechnology sector, potentially impacting its market presence and stakeholder interests positively.
More about Chimeric Therapeutics Ltd.
Chimeric Therapeutics Limited operates in the biotechnology industry, focusing on the development of innovative therapies. The company is primarily involved in creating and advancing cell therapy products aimed at treating cancer, with a significant emphasis on leveraging cutting-edge technologies to improve patient outcomes.
Technical Sentiment Signal: Sell
Current Market Cap: A$14.81M
Find detailed analytics on CHM stock on TipRanks’ Stock Analysis page.